Celadon Pharmaceuticals Plc (AIM:CEL)
London
· Delayed Price · Currency is GBP · Price in GBX 8.00
+0.50 (6.67%)
Mar 28, 2025, 4:29 PM GMT+1
Celadon Pharmaceuticals Market Cap
Celadon Pharmaceuticals has a market cap or net worth of 5.51 million as of March 28, 2025. Its market cap has decreased by -91.20% in one year.
Market Cap
5.51M
Enterprise Value
10.29M
Revenue
130.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
8.00
Market Cap Chart
Since March 29, 2022, Celadon Pharmaceuticals's market cap has decreased from 89.42M to 5.51M, a decrease of -93.84%. That is a compound annual growth rate of -60.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 5.51M | -46.67% |
| Dec 31, 2024 | 10.33M | -86.01% |
| Dec 29, 2023 | 73.84M | 137.10% |
| Dec 30, 2022 | 31.14M | -65.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.02B |
| GSK plc | 60.68B |
| Haleon | 35.23B |
| Smith & Nephew | 9.36B |
| ConvaTec Group | 5.28B |
| Hikma Pharmaceuticals | 4.33B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.24B |